Ovarian Cancer GOG 213

March 13, 2013

Location: The Hospital of Central Connecticut

A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination with Bevacizumab Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer.